Overview of Status of Analysis, Design, Fabrication, Tests, etc.
Met with this quarter’s senior design team to learn about model objectives and current progress.
Conducted literature reviews to understand how we can implement RF in the most developed design.
Accomplishments from Previous Week
Planned our risk reduction component and started the presentation.
Started working on individual component analysis.
Gained deeper understanding about the project requirements and its objectives.
Communicated and met with one of the sponsors to discuss next quarter’s aims.
Goals for Next Week (list names after each item). Use specific and measurable objectives.
Design risk reduction using current team’s prototype.
Conduct more literature reviews to gain better understanding about the microneedling device, strengths/weaknesses of needles, and how to implement RF to the current model.
Perform tests on the most recent prototype and analyze the results.
Finalize next quarter’s objectives based on sponsor’s opinions/thoughts on winter quarter’s team model.
Sponsor Comments from Last Meeting and Actions Taken to Address these Comments (indicate date of comments and if via email or in person)
Send email with all team members.
Meet again during week 10 with the winter quarter team to plan what needs to be done next quarter.
Instructor Comments from Last Meeting and Actions Taken to Address these Comments (indicate date of comments and if via email or in person)
Main focus was to explore top priorities; talk to the sponsor about it.
Focus on how we can optimize the current team’s prototype.
Exploring needles and how it affects the patients: Assigned as an individual component analysis
Meet with current team members: Done.
Read about RF and how to apply it for our device: Assigned as an individual component analysis
Talked with Steve: Done.
Explore storage tank: Assigned as an individual component analysis
Think about possible optimizations for the current model.
Comments from Other Students in the Class (indicate date of comments and if via email or in person)
N/A
Risks and Areas of Concern
Structure or materials of needles may deform/break during injection.
Energy could impact conditions of the injected agent.
Applying RF to the prototype.
Resources or Information Required but not Available
Winter quarter’s latest progress on their prototype: will find out during sponsor’s meeting in week 10
Schedule
Describe upcoming milestone:
Finish risk reduction
Risk reduction presentation
Finish documents due final week
Budget (list amount spent and amount remaining)
N/A
Progress on Report and Webpage
Webpage: started home page, team member page, and internal pages